Hanae Armitage is a science writer and Associate Editor at Stanford University. With a focus on local issues in California and Stanford, Hanae's articles cover a range of topics including public health, mental health, addiction treatment, and advancements in medical technology. Her work has also been featured in Own Your Futurity.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Hanae Armitage's coverage focuses on healthcare, pharmaceuticals, and health & wellbeing topics with a local geographic focus on the United States, specifically California and Stanford. Her articles often include cited data and expert commentary.
Given her emphasis on citing data and featuring expert commentary in healthcare-related articles, she may be interested in pitches from professionals who can provide evidence-based insights or share new research findings related to mental health, addiction treatment, menopause care, vaccine technology advancements, or digital tools for addressing health issues. Additionally, experts with knowledge of Native heritage in medicine may find opportunities to contribute given Hanae’s past coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Genomics and technology development expert Lars Steinmetz now leads Stanford Medicine’s genetics department.
By: Emily Moskal, Rachel Tompa, Hanae Armitage, Nina Bai, Mark Conley
Stanford Medicine scientists are studying why even brief trips into space can weaken muscle and heart tissue, mimicking decades of aging on Earth.
Experts from academia, industry, the humanities and more gathered on the Stanford Medicine campus to pitch their concepts for the future of medicine.
More than 130 new graduate students in 16 specialties received a warm welcome — and lab coats — as they began their doctoral studies at Stanford Medicine.
By: Hanae Armitage, Bruce Goldman, Erin Digitale, Hadley Leggett
Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.
Welcome to Stanford Medicine's Health Compass podcast, your go-to source for bringing the latest medical research to life through engaging and relatable stories that connect with your everyday health experiences. Join Maya Adam, MD, Director of Health Media Innovation and a Stanford Medicine faculty member, as she interviews leading experts on crucial health topics featured in Stanford Medicine
Around 1.5 billion people globally experience some level of hearing loss -- that's nearly 20% of the world's population. Losing the ability to hear can be devastating, and navigating the potential treatments isn't always straight forward.
By: Hanae Armitage
New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.
The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed with a rare cardiovascular disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.
By: Beth Duff-Brown
The COVID-19 pandemic accelerated the transition from in-person care to virtual care, as office visits increasingly gave way to televisits and email exchanges. The transition, while helpful during lockdowns, means that physicians now juggle packed schedules with increased electronic documentation and overstuffed inboxes.
(833) 317-6278 
